Tapewire

Nasdaq · USD

AEMD

AETHLON MEDICAL INC

Export transactions ↓
Tapewire entity
8580
SEC CIK
0000882291
Parsed reports
210

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2016 Filed Sep 6, 2016 18:55 UTC Exercise / conversionCommon Stock 12,328 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000020 · broenniman_frm4.xml · nonDerivative · entry 1

BROENNIMAN EDWARD G · CIK 0001284599 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement in common stock of previously issued restricted stock units upon vesting of such units.

F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. For tax purposes, each share of common stock was valued at $6.28, the closing price of the common stock on 8/9/16, the date of grant.

F3 · balance_after: In addition to the currently outstanding shares of common stock owned by the reporting person and reported here, the reporting person also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 10,000 shares of common stock at $20.50 per share, options to purchase 12,000 shares of common stock at $12.50 per share, options to purchase 9,211 shares of common stock at $3.80 per share, options to purchase 8,537 shares of common stock at $4.10 per share, options to purchase 3,684 shares of common stock at $9.50 per share and 1,368 restricted stock units.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 18:54 UTC Exercise / conversionRestricted Stock Units · Derivative 12,328 $0.00 $0.00
Disclosure

SEC source: 0001683168-16-000019 · barry_frm4.xml · derivative · entry 3

BARRY FRANKLYN S JR · CIK 0001254761 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,104

Underlying: Common Stock · 12,328 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. For tax purposes, each share of common stock was valued at $6.28, the closing price of the common stock on 8/9/16, the date of grant.

F5 · derivative.exercise_date: 12,328 of the restricted stock units vested on the grant date, 8/9/16, and 1,368 of the remaining restricted stock units will vest on each of 9/30/16, 12/31/16 and 3/31/17.

F5 · derivative.expiration_date: 12,328 of the restricted stock units vested on the grant date, 8/9/16, and 1,368 of the remaining restricted stock units will vest on each of 9/30/16, 12/31/16 and 3/31/17.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 18:54 UTC Tax withholdingCommon Stock 4,931 $6.28 $30,966.68
Disclosure

SEC source: 0001683168-16-000019 · barry_frm4.xml · nonDerivative · entry 2

BARRY FRANKLYN S JR · CIK 0001254761 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,519

F4 · shares: Represents shares of common stock withheld and deemed sold to the issuer to satisfy the tax obligation of the reporting person due upon vesting of the restricted stock units.

F3 · balance_after: In addition to the currently outstanding shares of common stock owned by the reporting person and reported here, the reporting person also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 10,000 shares of common stock at $20.50 per share, options to purchase 10,000 shares of common stock at $12.50 per share, options to purchase 9,211 shares of common stock at $3.80 per share, options to purchase 8,537 shares of common stock at $4.10 per share, options to purchase 3,684 shares of common stock at $9.50 per share and 1,368 restricted stock units.

Read SEC document
September 01, 2016 Filed Sep 6, 2016 18:54 UTC Exercise / conversionCommon Stock 12,328 Not disclosed Not disclosed
Disclosure

SEC source: 0001683168-16-000019 · barry_frm4.xml · nonDerivative · entry 1

BARRY FRANKLYN S JR · CIK 0001254761 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement in common stock of previously issued restricted stock units upon vesting of such units.

F2 · price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. For tax purposes, each share of common stock was valued at $6.28, the closing price of the common stock on 8/9/16, the date of grant.

F3 · balance_after: In addition to the currently outstanding shares of common stock owned by the reporting person and reported here, the reporting person also beneficially owns the shares of common stock underlying the following stock options and restricted stock units: options to purchase 10,000 shares of common stock at $20.50 per share, options to purchase 10,000 shares of common stock at $12.50 per share, options to purchase 9,211 shares of common stock at $3.80 per share, options to purchase 8,537 shares of common stock at $4.10 per share, options to purchase 3,684 shares of common stock at $9.50 per share and 1,368 restricted stock units.

Read SEC document
August 09, 2016 Filed May 15, 2019 01:08 UTC Amendment
FRAKES JAMES BChief Financial Officer
GrantCommon Stock 52,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-029816 · doc4a.xml · nonDerivative · entry 1

FRAKES JAMES B · CIK 0001185553 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,200

F1 · acquired: RSU was originally reported in Table II of the Reporting Person's Form 4 filed 08/11/2016.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.